Imaging as a surrogate marker of drug efficacy in cardiovascular disease
Abstract
### Learning objectives
Many cardiovascular drugs in the pipeline will fail to demonstrate a clear clinical benefit when evaluated in large-scale clinical outcome trials, which are costly, require lengthy follow-up and can potentially expose patients to unforeseen risks. There exists an enormous gap between early mechanistic studies demonstrating proof-of-principle drug efficacy in preclinical models and successful translation of these...
Paper Details
Title
Imaging as a surrogate marker of drug efficacy in cardiovascular disease
Published Date
Oct 31, 2018
Journal
Volume
105
Issue
7
Pages
567 - 578
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History